ReviewBMC pulmonary medicine2025
Concurrent e-cigarette or vaping product use-associated lung injury (EVALI) and myopericarditis: a rare case report and literature review.
Review in BMC pulmonary medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWith the rise in vaping both in Vietnam and globally, acute complications related to vaping are becoming increasingly recognized. Although lung injury is the most common clinical presentation, instances of cardiac damage, including pericardial involvement, albeit less frequently, have also been reported. We describe what is, to our knowledge, the first reported instance of an adolescent who developed acute respiratory distress syndrome and myopericarditis in temporal association with vaping. CASE PRESENTATION: A previously healthy 17-year-old male resumed heavy e-cigarette use three days before experiencing sudden pleuritic chest pain and dyspnoea. On admission, he rapidly progressed to hypoxaemic respiratory failure requiring mechanical ventilation and vasopressor support. Chest X-ray bilateral opacities, consistent with EVALI. Transthoracic echocardiography revealed a circumferential pericardial effusion (up to 14 mm) without ventricular dysfunction. Cardiac biomarkers were markedly elevated. Diagnosed with e-cigarette, or vaping-associated lung injury (EVALI) and myopericarditis, lung-protective ventilation, intravenous methylprednisolone and empiric broad-spectrum antibiotics were instituted. The patient responded well to the corticosteroid treatment. Follow-up imaging confirmed near-complete resolution of pulmonary infiltrates and complete resolution of the pericardial effusion. He has remained asymptomatic at three-month review after counselling to cease vaping. A review of the literature on acute cardiac complications associated with e-cigarettes suggests that these complications may be underrecognized.
conclusionsThis case highlights that vaping-related injury can extend beyond the lungs, eliciting simultaneous fulminant pulmonary and cardiac inflammation. Clinicians should maintain a high index of suspicion for EVALI and associated extrapulmonary issues like myopericarditis in young patients presenting with acute cardiorespiratory failure following e-cigarette use and should obtain a detailed vaping history to guide timely diagnosis and corticosteroid therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.